Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody Treatment

26 Apr 2020

Abstract excerpt

New coronavirus (SARS-CoV-2) treatments and vaccines are under development to combat COVID-19. Several approaches are being used by scientists for investigation, including (1) various small molecule approaches targeting RNA polymerase, 3C-like protease, and RNA endonuclease; and (2) exploration of antibodies obtained from convalescent plasma from patients who have recovered from COVID-19. The coronavirus genome...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to SARS-CoV-2 and COVID-19 Research
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32357545
DOI: 10.3390/pathogens9050324

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody TreatmentPMID 32357545Read ↗

Emergence of Drift Variants That May Affect COVID-19 Vaccine Development and Antibody TreatmentSemantic proximity Read ↗

A Comprehensive Account of SARS-CoV-2 Genome structure, Incurred mutations, Lineages and COVID-19 Vaccination ProgramSemantic proximity Read ↗

Rapidly Evolving SARS-CoV-2: A Brief Review Regarding the Variants and their Effects on Vaccine Efficacies.Semantic proximity Read ↗

The COVID-19 pandemic: viral variants and vaccine efficacySemantic proximity Read ↗

Emerging Vaccine-Breakthrough SARS-CoV-2 VariantsSemantic proximity Read ↗

Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants.Semantic proximity Read ↗

Genomic Diversity and Evolution, Diagnosis, Prevention, and Therapeutics of the Pandemic COVID-19 DiseaseSemantic proximity Read ↗

Antigenic drift: Understanding COVID-19.Semantic proximity Read ↗

COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy.Semantic proximity Read ↗

COVID-19: comprehensive review on mutations and current vaccines.Semantic proximity Read ↗

Nucleocapsid as a next-generation COVID-19 vaccine candidateSemantic proximity Read ↗

COVID-19: Challenges of Viral VariantsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.